Cargando…
Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy
Resveratrol (3, 4′, 5-trihydroxy-trans-stilbene, RSV), a nutraceutical, has recently attracted lots of attention because of its outstanding pharmacological potential. The effects of RSV on non-alcoholic fatty liver disease (NAFLD) remain inconclusive, although a wealth of research has been done. The...
Autores principales: | Wan, Shuqian, Zhang, Long, Quan, Yunyun, Wei, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281916/ https://www.ncbi.nlm.nih.gov/pubmed/30564426 http://dx.doi.org/10.1098/rsos.181457 |
Ejemplares similares
-
Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’
por: Wan, S., et al.
Publicado: (2019) -
Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells
por: Nassir, Anmar M., et al.
Publicado: (2018) -
Effect of resveratrol on non-alcoholic fatty liver disease
por: Theodotou, Marios, et al.
Publicado: (2019) -
Improving the low solubility of resveratrol
por: Atanacković, Milica T, et al.
Publicado: (2012) -
Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity
por: Siu, Frederick YK, et al.
Publicado: (2018)